ArticlePloS one2026
Prognostic risk model based on cholesterol metabolism-Associated gene module for idiopathic pulmonary fibrosis.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIdiopathic Pulmonary Fibrosis (IPF) is a progressive and fatal lung fibrosis disease with a complex molecular mechanism that remains incompletely understood. Previous studies suggest that metabolic dysregulation, particularly cholesterol metabolism, may play an essential role in the onset and progression of IPF. However, the role of cholesterol metabolism-related genes in IPF and their relationship with prognosis have not been thoroughly explored. This study aims to systematically analyze the potential function of cholesterol metabolism-associated genes in IPF by using bulk transcriptomic data to construct a prognostic risk model and single-cell RNA sequencing data to characterize the cellular context of the model genes.
methodsTranscriptomic data (GSE150910 and GSE93606) and single-cell RNA sequencing data from IPF patients were obtained from the GEO database. Differential gene expression analysis was performed using DESeq2 and limma packages to identify significant differentially expressed genes, and a cholesterol metabolism-related gene module was constructed through WGCNA. Subsequently, key cholesterol metabolism genes associated with IPF prognosis were screened using univariate Cox regression and LASSO regression. A prognostic risk model was developed based on the selected biomarkers, and its predictive performance was evaluated using Kaplan-Meier survival curves and ROC curves. To explore the potential biological functions of these genes and their mechanisms in IPF, immune infiltration analysis, GO and KEGG functional enrichment analysis, protein-protein interaction (PPI) network analysis, and GSEA were performed. Finally, mRNA of these genes were validated in animal models.
resultsA total of 19 differentially expressed cholesterol metabolism-related genes were identified from IPF patients. Through univariate Cox and LASSO regression, three key genes (PDLIM7, CFAP45, and HP) were selected, and a prognostic risk model for IPF patients was constructed based on these three genes. Kaplan-Meier survival analysis and ROC curves showed that the model demonstrated high predictive performance in both the training and validation cohorts (Area Under the Curve > 0.70). Additionally, immune infiltration analysis revealed significant differences in immune cell infiltration between the high-risk and low-risk groups, suggesting that cholesterol metabolism and immune regulation are closely linked to the progression of IPF. GSEA enrichment analysis highlighted pathways related to lipid metabolism and inflammatory response that were significantly enriched in the high-risk group, and animal experiments showed elevated mRNA expression of these genes in the lungs of fibrotic mice.
conclusionThis study constructed a prognostic risk model for IPF using genes derived from a cholesterol metabolism-associated module, and explored their potential roles in IPF progression.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.